Literature DB >> 26629159

The relationship between the target effective site concentration of rocuronium and the degree of recovery from neuromuscular blockade in elderly patients.

Xiaochong Fan1, Minyu Ma1, Zhisong Li1, Shengkai Gong1, Wei Zhang1, Yuanyuan Wen1.   

Abstract

OBJECTIVE: To study the relationship between the target effective site concentration (Ce) of rocuronium and the degree of recovery from neuromuscular blockade in elderly patients.
METHODS: 50 elderly patients (ASA grade II) scheduled for selective surgical procedure under general anaesthesia were randomly divided into two groups, A and B, with 25 cases in each group. The Ce of rocuronium for intubation was 3 μg·ml(-1) in both groups, and the Ce during operation were 0.8 and 1.0 μg·ml(-1) in group A and B, respectively. When target controlled infusion of rocuronium was stopped, without the administration of reversal agents for neuromuscular blockade, the relationship between Ce and the first twitch height (T1) was studied by regression analysis.
RESULTS: There was a significant linear relationship between Ce and T1, and there was no statistical difference in regression coefficient and interception between group A and B (P>0.05).
CONCLUSION: The degree of recovery from neuromuscular blockade could be judged by the target effective site concentration of rocuronium at the time of reversal from neuromuscular blockade in the elderly patients.

Entities:  

Keywords:  Rocuronium; geriatrics; neuromuscular blockade; pharmacodynamics

Year:  2015        PMID: 26629159      PMCID: PMC4659047     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  10 in total

Review 1.  Pharmacokinetic studies of neuromuscular blocking agents: good clinical research practice (GCRP).

Authors:  J Viby-Mogensen; D Ostergaard; F Donati; D Fisher; J Hunter; J P Kampmann; A Kopman; J H Proost; S N Rasmussen; L T Skovgaard; F Varin; P M Wright
Journal:  Acta Anaesthesiol Scand       Date:  2000-11       Impact factor: 2.105

2.  Target controlled infusion of rocuronium: analysis of effect data to select a pharmacokinetic model.

Authors:  K M Vermeyen; V L Hoffmann; V Saldien
Journal:  Br J Anaesth       Date:  2003-02       Impact factor: 9.166

3.  Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.

Authors:  T Fuchs-Buder; C Claudius; L T Skovgaard; L I Eriksson; R K Mirakhur; J Viby-Mogensen
Journal:  Acta Anaesthesiol Scand       Date:  2007-08       Impact factor: 2.105

4.  The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.

Authors:  J M Wierda; U W Kleef; L M Lambalk; W D Kloppenburg; S Agoston
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

Review 5.  Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents.

Authors:  J Viby-Mogensen; J Engbaek; L I Eriksson; L Gramstad; E Jensen; F S Jensen; Z Koscielniak-Nielsen; L T Skovgaard; D Ostergaard
Journal:  Acta Anaesthesiol Scand       Date:  1996-01       Impact factor: 2.105

Review 6.  Clinical pharmacokinetics of rocuronium bromide.

Authors:  K S Khuenl-Brady; H Sparr
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

7.  Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children.

Authors:  J M Wierda; O A Meretoja; T Taivainen; J H Proost
Journal:  Br J Anaesth       Date:  1997-06       Impact factor: 9.166

8.  Catecholamines and regional hemodynamics during isovolemic hemodilution in anesthetized pigs.

Authors:  E C Van Woerkens; A Trouwborst; D J Duncker; M M Koning; F Boomsma; P D Verdouw
Journal:  J Appl Physiol (1985)       Date:  1992-02

9.  Pharmacokinetics and pharmacodynamics of rocuronium at the vocal cords and the adductor pollicis in humans.

Authors:  B Plaud; J H Proost; J M Wierda; J Barre; B Debaene; C Meistelman
Journal:  Clin Pharmacol Ther       Date:  1995-08       Impact factor: 6.875

10.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

  10 in total
  1 in total

Review 1.  Newer drug delivery systems in anesthesia.

Authors:  Sona Dave; Deepa Shriyan; Pinakin Gujjar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.